Ssi Strategy

the pharmaceutical industry is undergoing unprecedented change in both the fundamental structure and function of companies as well as profound alterations in the macroeconomic environment. at the core of these changes is continual pressure to optimize the collection, analysis, and communication of medical and scientific data to a widely divergent group of increasingly sophisticated stakeholders, including payors, clinicians, regulatory authorities, elected officials, patients and patient advocacy groups. ssi strategy was originally launched as a dynamic consultancy focused primarily on pharmacovigilance advice and drug safety-related services. the company rapidly forged strong relationships as a strategic business partner, adding to ssi strategy capabilities that now include pharmacovigilance, medical affairs, regulatory affairs, pharmaceutical product lifecycles, business development and new product launch strategy and execution. we have partnered with acquis consulting group, a full-